ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVXL Anavex Life Sciences Corporation

3.85
0.05 (1.32%)
After Hours
Last Updated: 18:31:58
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Anavex Life Sciences Corporation AVXL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 1.32% 3.85 18:31:58
Open Price Low Price High Price Close Price Prev Close
3.76 3.60 3.80 3.78 3.80
more quote information »

Recent News

Date Time Source Heading
4/19/202405:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
4/16/202405:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
4/12/202405:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
4/11/202407:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
4/09/202405:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
4/05/202405:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
4/02/202405:45PRNUSShareholders that lost money on Anavex Life Sciences..
3/29/202405:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
3/26/202405:45PRNUSInvestors who lost money on Anavex Life Sciences..
3/25/202407:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
3/22/202405:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
3/18/202407:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
2/26/202407:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
2/23/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/07/202416:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/202407:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
2/01/202407:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
1/25/202417:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202407:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
1/16/202407:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
1/12/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202407:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
1/03/202407:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
1/02/202408:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
12/20/202307:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
12/19/202307:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
11/27/202316:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/27/202308:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
11/27/202306:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
11/24/202308:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
11/22/202308:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
11/20/202308:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
11/06/202308:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
10/25/202308:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
9/14/202307:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
9/12/202307:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
8/08/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
8/07/202307:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
8/02/202307:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
8/01/202307:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
6/28/202307:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
6/27/202307:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
6/20/202307:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
6/15/202307:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..
6/12/202307:30GLOBEAnavex Life Sciences Reports Publication in Medical Journal..

Your Recent History

Delayed Upgrade Clock